Adlhoch C, Dabrera G, Penttinen P, Pebody R; Count. Protective Measures for Humans against Avian Influenza A(H5N8) Outbreaks in 22 European Union/European Economic Area Countries and Israel, 2016-17. Emerg Infect Dis. 2018 Oct 17;24(10).
We sought to better understand national approaches for managing potential human health risks during outbreaks of infection with avian influenza A(H5N8) virus during 2017-17. Twenty-three countries in the Union/European Economic Area and Israel participated in this study. Risk to the general public was assessed as low in 18 countries and medium in 1 country. Of 524 exposed persons identified, 274 were passively monitored and 250 were actively monitored. Of 29 persons tested, all were negative for H5N8 virus. Vaccination and antiviral drug recommendations varied across countries. A high level of personal protection was recommended although a low risk was assessed. No transmission of this virus to humans was identified.
See Also:
Latest articles in those days:
- The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease 7 minute(s) ago
- Human infection caused by avian influenza A (H10N5) virus 12 minute(s) ago
- Cross-species spill-over potential of the H9N2 bat influenza A virus 13 hours ago
- Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets 13 hours ago
- Epidemiological characteristics of human infections with avian influenza A(H5N6) virus, China and Laos: A multiple case descriptive analysis, February 2014-June 2023 1 days ago
[Go Top] [Close Window]